Close

Immunogen (IMGN) Misses Q2 EPS by 2c

January 29, 2016 6:31 AM EST

Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Immunogen (IMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings